Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings. It works with health systems and global pharmaceutical companies to expand patient access to high-cost treatments outside traditional hospital settings.
3 investors
Current Surgical develops a smart needle technology platform for surgical treatment of cancerous tumors. The company serves surgeons and oncologists in the medical device and cancer care space.
3 investors
Cydar Medical provides cloud-based software that uses AI and data fusion to give surgical and clinical teams imaging insights during procedures, aiming to reduce radiation exposure, procedure times, and contrast agent use. Its platform, including Cydar Maps and a companion app, supports clinical teams and hospital enterprises with case coordination, workflow integration, and operating room resource optimization.
3 investors
Cyfuse Biomedical develops a platform technology that builds three-dimensional tissues and organs from spheroids using its proprietary Bio 3D Printer. Its products include the Bio 3D Printer, an in vitro liver-function evaluation tool for drug discovery support, and regenerative-medicine 3D cell products made entirely from cells.
3 investors
Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets. The company serves the life sciences research and drug development sectors.
3 investors
Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's. The platform targets healthcare providers, patients, and pharmaceutical companies seeking to advance brain health and disease prevention.
3 investors
Data-Driven Bioscience develops Duoseq, a cancer genomics platform that performs simultaneous DNA and RNA analysis from a single sample, delivering comprehensive molecular profiling results in two days for use in clinical diagnostics and research.
3 investors
DSI provides scientific services for preclinical research, including implanted telemetry support, in vivo study execution, data analysis and reporting, and GLP validation. It serves researchers and laboratories conducting physiological studies such as cardiovascular and respiratory monitoring in animal models.
3 investors
Deepnoid develops generative AI agents for medical image interpretation and radiology reporting, including its M4CXR technology for chest X-ray analysis. The company builds AI tools to support clinicians in reading medical images and generating reports.
3 investors
DDT (Delta Dev Team) builds integrated blood and medical cold-chain management systems, replacing fragmented devices with connected, data-driven readiness tools for prehospital and medical logistics. It serves EMS, military, humanitarian, and healthcare systems to keep blood and critical medical supplies protected and available.
3 investors
Design Therapeutics is a biopharmaceutical company developing small molecule therapeutic candidates for serious genetic diseases through its GeneTAC (Gene Targeted Chimera) platform. Its pipeline focuses on monogenic repeat expansion disorders such as Friedreich ataxia, Fuchs endothelial corneal dystrophy, myotonic dystrophy, and Huntington's disease.
3 investors
Difinity develops medical devices and technologies focused on emergency medication delivery and needle safety. The company is engineering an automatic injection device with interchangeable pods for use in emergency medical situations, and a safer hypodermic needle delivery system called NeedSafe.
3 investors
Dyne Therapeutics develops targeted therapies for genetically driven neuromuscular diseases using its proprietary FORCE platform. The company focuses on discovery, clinical development, and commercialization of treatments for rare genetic disorders.
3 investors
Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding. It is a medical device for people with hearing loss.
3 investors
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software. It serves the cardiology and electrophysiology field, targeting patient treatment backed by clinical evidence.
3 investors
EBR Systems develops the WiSE cardiac pacing system, a leadless and physiologic medical device for treating heart failure patients. The company serves physicians and hospitals providing cardiac rhythm management and conduction system pacing solutions.
3 investors
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder. The clinical-stage company, spun out of the University of Toronto, is advancing paradigm-shifting medical devices for patients with pelvic health conditions.
3 investors
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
3 investors
Elixir Therapeutics develops therapies for rare diseases and aging-related conditions using proprietary technologies, including ZSCAN4 for telomere extension in stem cell therapies and Bobcat mRNA for delivering large genes. The company is advancing clinical candidates for telomere biology disorders and Duchenne muscular dystrophy.
3 investors
Elucid offers PlaqueIQ, a non-invasive CT-based plaque analysis tool for cardiologists and radiologists to assess coronary and carotid plaque composition and enable patient-specific treatment pathways for cardiovascular disease prevention.
3 investors
Empo Health develops in-home health monitoring devices for diabetic patients and healthcare providers to improve care outcomes. The company serves diabetes management in the digital health space.
3 investors
Endomag develops magnetically-guided surgical technologies, including its Sentimag platform and Magtrace marker, to help physicians locate and remove breast cancer without wires or radioactive tracers. Its products serve breast cancer surgeons and their patients, aiming for more precise, less invasive procedures.
3 investors
Endomedix is developing PLEXimine, a technology platform based on polysaccharide chemistry that lets surgeons form structured medical devices in situ during procedures. The company focuses on biosurgery and related medical applications.
3 investors
EndoShunt develops a catheter-based device to control hemorrhage in traumatic vascular injuries, featuring a length-adjustable occlusion zone, temporary deployment, and an atraumatic tip. The company has functional prototypes validated in benchtop and in vivo studies and is pursuing FDA 510(k) clearance.
3 investors